Search results for: revocation

Supplementary Protection Certificates

We can help you secure a patent term extension to compensate for the time it takes for your new drug to pass clinical trials and receive marketing authorisation.  In many European countries, you�...

Third Party Observations

Third party observations are another tool that you can use alongside oppositions and national revocation actions.  Their purpose is to uphold your freedom to operate when it is challenged by a co...

Opposition Practice at the EPO – Advice for Patent Owners

Opposition proceedings at the EPO provide a time-limited opportunity for a third party to challenge the validity of a granted European patent centrally, with the aim of achieving revocation, or at lea...

Get Your Priorities Right – A Guide to Establishing and Maintaining a Valid Priority at the EPO

Background The patent priority system was established by the Paris Convention to provide an applicant with 1 year grace to get their foreign applications filed after filing their first (usually local)...

Oppositions at the European Patent Office – An Introduction | 15.12.20

Tuesday 15th December 2020, 2:00pm (London UK – BST) 45mins What will the talk cover? Gill Jennings & Every has one of the most experienced and active patent opposition practices in Europe, ...

GJE Partner, Arnie Clarke, Leads Successful Landmark Opposition Attack of Teva’s Key 2030 Patent (EP 2 949 335) On Behalf of Mylan

Arnie Clarke has recently been involved in the ground-breaking appeal relating to Teva’s key 2030 patent (EP 2 949 335).  Acting on behalf of Mylan, in front of the EPO board of appeal 3.3.04, ...

Being Heard and Seen – Oral Proceedings During the Time of Coronavirus

A recent decision of the Boards of Appeal of the European Patent Office makes it clear that oral proceedings can take place via videoconference.  This paves the way for the backlog of hearings that h...

Santen: A Clear View of Drug Repurposing and a Loss of Sleep for Those Relying on Neurim

The CJEU has dealt a massive blow to the drug repurposing sector with its decision in Santen, stripping companies of their right to Supplementary Protection Certificates (SPCs), and overturning one of...

The Medtech Patent Landscape in Numbers – 2020 Update

A few years ago we analysed the MedTech sector from a patents perspective (see here).  Many of the wider trends that we identified have continued, while there has been some shifting in the specif...

Marking Time: Do Patent Numbers Have Any Place on Watches and Other Luxury Goods?

We often advise clients that any product made in accordance with their granted patent should be suitably marked as patented.  While there is no requirement for this in UK law, patent marking of p...